会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明授权
    • Compounds
    • 化合物
    • US4211788A
    • 1980-07-08
    • US904794
    • 1978-05-11
    • Hugh CairnsAnthony R. Payne
    • Hugh CairnsAnthony R. Payne
    • C07D311/94A61K31/355C07D311/22
    • C07C45/60C07C45/62C07C45/67C07C45/71C07D311/94
    • There are described compounds of formula I, ##STR1## in which E is a --COOH, a 5-tetrazolyl or an (N-tetrazol-5-yl) carboxamido group,R.sub.3 is hydrogen or alkyl,an adjacent pair of W, X, Y and Z form a 5 membered chain comprising alkylene groups and optionally one or two oxygen atoms, the chain optionally being substituted by one or two alkyl groups,the remaining substituents W, X, Y or Z are hydrogen; halogen; alkyl optionally substituted by one or more of the groups hydroxy, halogen, carbonyl oxygen, phenyl, or alkoxy; alkenyl optionally substituted by phenyl; hydroxy; alkoxy; alkanoyloxy; alkenyloxy; nitro; --NR.sub.1 R.sub.2 or hydroxyalkoxy,R.sub.1 and R.sub.2, which may be the same or different, are each hydrogen or alkyl,and pharmaceutically acceptable derivatives thereof.There are also described processes for making the compounds and pharmaceutical, e.g. anti-allergic, compositions containing the compounds.
    • 描述了式I的化合物,其中E是-COOH,5-四唑基或(N-四唑-5-基)甲酰氨基,R 3是氢或烷基,相邻的一对W, X,Y和Z形成包含亚烷基和任选的一个或两个氧原子的5元链,该链任选被一个或两个烷基取代,其余的取代基W,X,Y或Z是氢; 卤素; 任选被一个或多个羟基,卤素,羰基氧,苯基或烷氧基取代的烷基; 任选被苯基取代的烯基; 羟基; 烷氧基 烷酰氧基; 链烯氧基 硝基 -NR1R2或羟基烷氧基,R1和R2可以相同或不同,各自为氢或烷基,及其药学上可接受的衍生物。 还描述了制备化合物和药物的方法,例如。 抗过敏剂,含有这些化合物的组合物。
    • 19. 发明授权
    • Bis-chromone-tetrazole/hydroxamic/carboxylic acids
    • 双色酮 - 四唑/异羟肟酸/羧酸
    • US3948954A
    • 1976-04-06
    • US435008
    • 1974-01-21
    • Hugh CairnsNorman Harold Rogers
    • Hugh CairnsNorman Harold Rogers
    • C07D311/02
    • There are described compounds of formula I, ##SPC1##in whichR.sub.1, r.sub.2, r.sub.3, r.sub.4, r.sub.5 and R.sub.6, which may be the same or different, each represent hydrogen, halogen, hydroxy, alkyl C1 to 6, alkoxy C1 to 6, alkenyl C1 to 6; the alkyl and alkoxy groups optionally being substituted by hydroxy, alkoxy C1 to 6, halogen or phenyl, andX is a hydrocarbon group containing from 2 to 10 carbon atoms, which is optionally interrupted by an oxygen atom, and/or substituted by an -OH group,Ra is a group -COOH, or ##EQU1## and pharmaceutically acceptable derivatives thereof. There are also described methods of making the compounds and pharmaceutical, e.g. anti-allergic, compositions containing them.
    • 描述了式I化合物,其中可以相同或不同的R 1,R 2,R 3,R 4,R 5和R 6各自表示氢,卤素,羟基,C 1-6烷基,烷氧基C 1-6,烯基C 1 至6; 任选被羟基,烷氧基C1至6,卤素或苯基取代的烷基和烷氧基,X是含有2-10个碳原子的烃基,其任选被氧原子中断,和/或被 - OH基,R a为-COOH基团,或-CN N ANGLE-ANGLE NH +及其药学上可接受的衍生物。